Boston, June 03, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, the “Global Epigenetics Markets” is projected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029 at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.
The report offers quantitative and qualitative insights to help readers develop growth strategies, assess the market landscape and make informed business decisions. It covers various therapeutic classes, such as DNMT inhibitors, HDAC inhibitors, IDH inhibitors and EZH2 inhibitors.
The report is segmented by study methods, clinical indications and drug classes. Additionally, it discusses industry growth drivers, restraints, trends, opportunities, competitive landscape and emerging technologies impacting the epigenetics market.
The factors driving the market’s growth include:
Rising Cancer Rates: The increasing prevalence of cancer creates a demand for new treatments and diagnostic tools, driving epigenetic research to develop targeted therapies.
Technological Advances: Innovations in tools like CRISPR and next-generation sequencing enhance our ability to study and manipulate epigenetic modifications, leading to better disease understanding and treatment.
Increased Research Funding: More investment in biomedical research supports the development of new technologies and therapies, fostering innovation in epigenetics.
Precision Medicine: The trend toward personalized treatments based on genetic profiles boosts the importance of epigenetics in developing effective, individualized therapies.
Interest in Liquid Biopsy: Liquid biopsies offer a noninvasive way to detect and monitor diseases, and technological improvements are increasing their clinical adoption.
Request a sample copy of the global market for epigenetics research tools and reagents, IVDs and therapeutics reports.
Report Synopsis
| Report Metric | Details |
| Base year considered | 2023 |
| Forecast period considered | 2024-2029 |
| Base year market size | $4.4 billion |
| Market size forecast | $8.5 billion |
| Growth rate | CAGR of 11.8% from 2024 to 2029 |
| Segments covered | Product type, study method, clinical indication, drug class and region |
| Regions covered | North America, Europe, Asia-Pacific and the Rest of the World (RoW) |
| Market drivers |
|
Interesting facts:
- Epigenetic drugs have been more clinically successful in hematological malignancies than solid tumors.
- Many companies are developing epigenetic biomarker-based blood tests for early cancer detection. Multicancer detection is a significant area of interest.
- Most epigenetic drugs in clinical trials and on the market are primarily focused on oncology areas, particularly hematological malignancies.
Emerging startups:
- Helio Genomics: The company is developing a blood test for early cancer detection.
- Biomea Fusion Inc.: A clinical-stage biopharmaceutical company focused on the discovery and development of oral covalent small molecules to treat patients with metabolic disease and genetically defined cancers.
The report addresses the following questions:
- What is the projected market size and growth rate of the epigenetics research tools, reagents, IVDs and therapeutics market?
- The global epigenetics market was estimated to be around $4.4 billion in 2023. It is projected to reach $8.5 billion in 2029, growing at a CAGR of 11.8% during the forecast period.
- What market segments are covered in the report?
- An in-depth analysis of the global epigenetics research tools, reagents, IVDs and therapeutics market, including historical data and market projection on sales by product type, study method, clinical indication, drug class and region.
- Which type segment will dominate the market by the end of 2029?
- The IVD type segment is anticipated to dominate the market by the end of 2029.
- Which market is growing fastest among all?
- The IVD segment is the fastest growing market.
Leading companies in the market include:
- ACTIVE MOTIF INC.
- BIO-RAD LABORATORIES INC.
- BIO-TECHNE
- BRISTOL-MYERS SQUIBB CO.
- DAIICHI SANKYO CO., LTD.
- EXACT SCIENCES CORP.
- GUARDANT HEALTH
- HOLOGIC INC.
- LES LABORATOIRES SERVIER
- MERCK KGAA
- NUCLEIX
- PROMEGA CORP.
- QIAGEN
- REVVITY INC. (PERKINELMER)
- THERMO FISHER SCIENTIFIC INC.
Related reports Include:
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets: This report examines the industry structure, competitive landscape and profiles of leading companies, including their products, financials and recent activities. It also evaluates business strategies in the competitive environment and segments the market by application, analysis purpose, biomarker type and platform. Regional analysis spans North America, Europe, Asia-Pacific and the Rest of the world.
Global DNA Sequencing: Research, Applied and Clinical Markets: The report on DNA sequencing explores its current and future market potential, analyzing drivers, restraints and opportunities. The market is segmented by technology (NGS, TGS, pyrosequencing and Sanger sequencing), product and service, end user, application, disease category and region. Key regions covered are North America, Europe, Asia-Pacific and the Rest of the World.
Navigate Uncertainty with Confidence
In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we’re offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights.
Purchase a copy of the report directly from BCC Research.
For further information on any of these reports or to make a purchase, contact info@bccresearch.com.
About BCC Research
BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts’ goal is to help you make informed business decisions free of noise and hype.
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.
Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.
BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@bccresearch.com Phone: +1 781-489-7301
Add Comment